Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine Liposome Injection for Acute Postoperative Pain After Pediatric Orthopedic Surgery
NCT06344091Phase 4Recruiting
- Sponsor
- Hengrui
- Start
- May 2024
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine liposome in acute postoperative pain, sponsored by Hengrui. Started May 2024; status: recruiting.
02
Drugs
bupivacaine liposome
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on NCT06344091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06344091.